Pinnow Cole — SEC Form 4 filings

SEC reporting owner CIK 2024135. 4 Form 4 filings on record with FilingPulse; latest filed 2025-12-19.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-05-29 to 2025-12-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Cogent Biosciences, Inc. (COGT)Chief Commercial Officer41 leg · 43,750 sh · $332,4126

Form 4 filings — Pinnow Cole

FiledFormIssuerReported transactionsSource
2025-12-194Cogent Biosciences, Inc. (COGT)Grant/award (A): 50,000 @ $0 · Grant/award (A): 214,000 @ $0 · Tax withholding (F): 94,800 @ $39.45 · Grant/award (A): 65,000 (derivative) @ $0EDGAR
2025-01-274Cogent Biosciences, Inc. (COGT)Grant/award (A): 240,000 (derivative) @ $0EDGAR
2025-01-154Cogent Biosciences, Inc. (COGT)Purchase (P): 43,750 @ $7.60EDGAR
2024-05-294Cogent Biosciences, Inc. (COGT)Grant/award (A): 525,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2024135 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →